• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library

    Enforcement Report - Week of January 15, 2025

    FDA

    Endo Issues Voluntary Nationwide Recall of Clonazepam Tablets

    FDA

    Par Pharmaceutical Issues Voluntary Nationwide Recall of One Lot of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution

    FDA

    Enforcement Report - Week of March 16, 2022

    FDA

    Enforcement Report - Week of September 2, 2020

    FDA

    Enforcement Report - Week of April 8, 2020

    FDA

    Enforcement Report - Week of March 25, 2020

    FDA

    Enforcement Report - Week of February 19, 2020

    FDA

    Enforcement Report - Week of May 15, 2019

    FDA

    Par Pharmaceutical recalls Mycophenolate Mofetil Injection, USP

    FDA

    Enforcement Report - Week of September 19, 2018

    FDA

    Enforcement Report - Week of September 12, 2018

    FDA

    Par Pharmaceutical Inc., Ongoing Class II recall of HydrALAZINE Hydrochloride Tablets, USP 25 mg, 100 count bottle Rx only, Distributed by: Par Pharmaceutical Companies, Inc. Spring Valley, NY10977 because of Presence of Foreign Substance: Par Pharmaceutical, Inc. is recalling one lot of HydrALAZINE Hydrochloride tablets due to the presence of small aluminum particles.

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.